Kenta Biotech Company Contacts

Kenta Biotech

http://www.kentabiotech.com
Kenta Biotech is focusing on the discovery and development of innovative, fully human monoclonal antibodies for the treatment of life-threatening hospital infections such as hospital acquired pneumonia. In spite of antibiotic treatment a significant number of patients still die from... Read More
Contacts

Country

Switzerland

City

Headquarters

undefined, CH

Profile

Founded

2006

Industry

Biotechnology Research

Size

11 - 50

Specialties

Research and development of fully human antibodies

Funding

Total Rounds

1

Last Round

Wed Mar 11 2009

Last Round Series

Series B

Last Round Raised

$ 10,096,140